The scientists from the Baker Heart and Diabetes Institute have devised a quick blood test have identified plasma lipid biomarkers which could easily predict the risk of oncoming secondary heart attack and stroke. These research findings were published in the journal named JCI Insight.

This invention is currently under development. But the team had proposed to conduct the trial in Australia as a customized precision health program during the next 2-3 years. In this trial work, the physician would order this test to detect the risk of heart disease.

Professor Peter Meikle, the lead investigator of this research work, said "While there are thousands of lipids in the blood, our challenge is to identify which ones best predict disease outcomes."

At first, a trial was conducted in America with the limited information based on only two lipid markers. This trial was not yet conducted anywhere.

Professor Peter Meikle said, "Our test will use up to ten lipid markers to better diagnose heart disease. It's a challenging, yet very exciting time. We effectively have the information and are in the process of refining the technology."

Professor Peter Meikle further added, "Once the protocols for a diagnostic heart disease blood test are in place; it will be possible to additional markers for the test to also be used in predicting diabetes and potentially Alzheimer's disease as well. The test will reclassify a patient's risk of heart attack and stroke. It will better identify who within the 'intermediate' risk category are in fact, at higher risk, and help guide physicians in the appropriate treatment of patients."

This blood test is similar to a cholesterol test, but it could be operated out of labs and hospitals.